Thomas Schurpf,Abhishek Datta,Gregory J. Carven,Constance Martin,Ashish Kalra,Kimberly Long,Alan Buckler
申请号：
US16361486
公开号：
US20190209682A1
申请日:
2019.03.22
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation.
